Home - CLL Global Research Foundation
The Latest President's Corner Newsletters Multimedia

NEWS & VIEWS: CLL Research Newsletters Archive

Tidbits e-newsletterTidbits is a lighter take on the happenings in the CLL research community. Click below to catch up previous issues or to sign up to receive Tidbits.

View the Tidbits Archive


 

Momentum logoRead CLL Research Momentum to stay informed about projects we are funding and progress made in the fight against CLL. pdf

 

Issue 2 - 2013 A True Hero: Mack Rankin • Protect Yourself Against the Flu • Landscape of CLL • New Projects • Start Using Cure with CLL?
Issue 1 - 2013 Passion & Means • Q&A: Dr. Neil Kay • Green Tea Update • CLL Research Wish List • New Projects
Issue 2 - 2012 MD Anderson Moon Shot • Summer Alliance Meeting • Expanding Collaborations • Targeted Treatments • Letter Writing Campaign • Grant Project Updates
Issue 1 - 2012 Chronic versus acute • Immunotherapy • Q&A: Dr. Stephan Stilgenbauer • New projects • Partnership opportunities
Issue 2 - 2011 Significance of historical information • Chimeric Antigen Receptors (CARs) • Q&A: Dr. Laurence Cooper • Bruton's tyrosine kinase • Partner Perspective: Will Newman
Issue 1 - 2011 Global collaborations • Alliance meeting • MicroRNAs • Q&A: Dr. George Calin • p53 • Stem cell transplant • Creative giving
Holiday 2010 Philanthropy will cure CLL • Mouse models • Signal transduction inhibitors • CLL in the elderly • Patient symposium • Prognostic factors • Cord blood transplant   
Summer 2010 State of CLL research • CLL Global’s history • Alliance meeting • Alliance collaborations • Researchers in the background • Projects reach clinic
Spring 2010 Genetics • Personalized therapy • Epstein-Barr virus • Clinical trial introduction • New projects
Fall 2009 Targeting ROR1 • CLL pathways • Relapsed CLL • Stem cell transplant introduction • Beyond FCR • Genetics • Skin cancer • TCL1
Summer 2009 Investing in CLL research • Genetics • FCR data • Microbead technology 
Winter 2008 How will CLL be cured? • Q&A: Dr. Emil J Freireich • Alliance update • 8-chloro-adenosine • New drugs • Secondary cancers • Flu shots • Ripple effect of grants
Summer 2008

Alliance introduction • Targeting proteins • Cellular signals • Alliance meeting • Minimal residual disease • CLL immunity collaboration • Immune system education • Proactive patient

Fall 2007 CLL microenvironment • Cure CLL now • Stat-3 • Single nucleotide polymorphisms • TCL1 • Alemtuzumab • Heavy water
Spring 2007

Familial CLL • Prognostic factors • Educating T-cells • Mapping genes • Gene modification • ZAP-70 • CD38

Fall 2006 Gene therapy studies • Initial grants • Green tea • Glycolycin • 8-chloro-adenosine • Protein expression • Indolent or aggressive CLL 

 

© 2012 CLL Global Research Foundation • P.O. Box 301402, Unit 428 • Houston, TX 77230

Home - CLL Global Research Foundation